Connect
MJA
MJA

Guidelines for the management of acute coronary syndromes 2006

John W Eikelboom, Graeme J Hankey and Paul E Langton
Med J Aust 2007; 186 (2): 101-102.
Published online: 15 January 2007

To the Editor: The guidelines for managing acute coronary syndromes, published in a supplement to the Journal in 2006, provide a readily accessible tool for clinicians to enhance patient care.1 However, unfortunately the recommendations concerning adjunctive anticoagulation in patients with acute coronary syndromes (ACS) are suboptimal.

  • John W Eikelboom1
  • Graeme J Hankey2
  • Paul E Langton3

  • 1 Thrombosis Service, McMaster Clinic, Hamilton, Ontario, Canada.
  • 2 University of Western Australia, Perth, WA.
  • 3 Hollywood Private Hospital, Perth, WA.

Correspondence: eikelbj@mcmaster.ca

Competing interests:

John Eikelboom has received honoraria and is currently the recipient of research funding from GlaxoSmithKline and Sanofi-Aventis; Graeme Hankey has received honoraria for consulting on advisory boards and speaking at sponsored scientific symposia by Sanofi-Aventis, Bristol-Myers Squibb, Bayer, Boehringer Ingelheim, AstraZeneca, and Pfizer pharmaceuticals; Paul Langton has received honoraria for consulting on advisory boards and speaking at sponsored scientific symposia by AstraZeneca, Bayer, Boehringer Ingelheim, Merck Sharp & Dohme, Pfizer, Sanofi-Aventis, Servier, and Solvay pharmaceuticals.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.